IGM Biosciences, Inc.
IGMS
$1.29
-$0.06-4.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 20.54% | 7.74% | 5.95% | -3.68% | -11.45% |
| Total Depreciation and Amortization | 10.09% | 11.83% | 22.75% | 34.90% | 36.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.45% | -18.42% | -19.49% | -7.04% | -2.60% |
| Change in Net Operating Assets | -6.16% | 88.09% | 102.41% | -103.14% | -104.31% |
| Cash from Operations | 20.41% | 8.73% | 7.92% | -922.50% | -3,184.32% |
| Capital Expenditure | 52.73% | 52.76% | 37.92% | 2.13% | -21.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.33% | -51.37% | -14.70% | 114.42% | 137.48% |
| Cash from Investing | -6.14% | -51.01% | -7.11% | 105.25% | 130.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.86% | -97.88% | -35.20% | -47.48% | -47.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -165.57% | -- |
| Cash from Financing | -97.92% | -97.94% | -35.30% | -47.51% | -47.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -881.49% | -4,808.98% | -19.05% | -194.77% | 27.30% |